Brain+ AS (OCSE:BRAINP) Other Income (Expense) : kr-4.88 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Brain+ AS Other Income (Expense)?

Brain+ AS's other income expense for the Brain+ AS's pretax income for the six months ended in Dec. 2023 was kr-4.88 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2023 was kr-4.88 Mil.

Brain+ AS Other Income (Expense) Historical Data

The historical data trend for Brain+ AS's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brain+ AS Other Income (Expense) Chart

Brain+ AS Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Expense)

0.10

-4.88

Brain+ AS Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Income (Expense)	Get a 7-Day Free Trial			0.11	-	-	-	-4.88

Brain+ AS Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-4.88 Mil.

Brain+ AS (OCSE:BRAINP) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Brain+ AS (OCSE:BRAINP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Brain+ AS (OCSE:BRAINP) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kobmagergade 53, 3rd Floor, Copenhagen, DNK, DK-1150

Website

https://www.brain-plus.com

Brain+ AS is a digital therapeutics company. It restores patients' quality of life by treating and detecting a cognitive decline in Alzheimer's disease and dementia through digital means. It has developed a set of Digital Medicine technologies. Its product pipeline includes CST Therapist Companion, and CST Home Companion; CST Home Care; CST for Mild Cognitive Impairment (MCI).

Brain+ AS (OCSE:BRAINP) Headlines

No Headlines